End-of-day quote
Shanghai S.E.
18:00:00 2024-07-14 EDT
5-day change
1st Jan Change
29.62
CNY
-4.85%
-0.37%
-46.63%
Bide Pharmatech Co., Ltd.'s Equity Buyback announced on December 9, 2023, has closed with 2,554,024 shares, representing 2.82% for CNY 99.99 million.
The company closed its plan on July 5, 2024.
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.
07-08
CI
Bide Pharmatech Co., Ltd.'s Equity Buyback announced on December 9, 2023, has closed with 2,554,024 shares, representing 2.82% for CNY 99.99 million.
07-04
CI
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.
07-02
CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
04-25
CI
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.
04-01
CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
02-02
CI
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.
01-03
CI
Bide Pharmatech Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
12-08
CI
Bide Pharmatech Co., Ltd. authorizes a Buyback Plan.
12-07
CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-27
CI
Bide Pharmatech Co., Ltd.(SHSE:688073) added to Shanghai Stock Exchange Composite Index
23-10-12
CI
Certain A Shares of Bide Pharmatech Co., Ltd. are subject to a Lock-Up Agreement Ending on 11-OCT-2023.
23-10-10
CI
Bide Pharmatech's Actual Controllers to Buy Up to 10 Million Yuan More Shares
23-09-20
MT
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-04
CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-19
CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-01-13
CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-27
CI
Bide Pharmatech Co., Ltd. has completed an IPO in the amount of CNY 1.428161 billion.
22-09-29
CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-09-14
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Bide Pharmatech Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The Company's main businesses are the research, development, design, production and sales of drug molecular building blocks. The Company's main products are pharmaceutical molecular building blocks and scientific reagents. The Company's products are mainly used in drug target discovery, seed compound screening, lead compound discovery, synthesis and optimization. The Company conducts business in Asia Pacific, India, Europe, the United States and other regions.
More about the company
Last Close Price
29.62
CNY
Average target price
41
CNY
Spread / Average Target
+38.42%
Consensus
1st Jan change
Capi.
-46.63% 362M +22.15% 46.56B +45.43% 41.67B -2.37% 41.16B +33.84% 32.4B -6.35% 28.1B +20.42% 28.18B +48.83% 14.52B +45.00% 13.74B +0.06% 12.17B
Other Biotechnology & Medical Research
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1